TRCT
KPRX icon

Tower Research Capital (TRC)’s Kiora Pharmaceuticals KPRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92K Sell
995
-589
-37% -$1.24K ﹤0.01% 4578
2025
Q4 		$3.12K Buy
+1,584
New +$3.61K ﹤0.01% 4420
2025
Q3 		– Sell
-439
Closed -$1.26K – 5437
2025
Q2 		$1.26K Sell
439
-1,746
-80% -$5.32K ﹤0.01% 4841
2025
Q1 		$6.58K Buy
2,185
+980
+81% +$3.4K ﹤0.01% 4031
2024
Q4 		$3.98K Sell
1,205
-749
-38% -$2.59K ﹤0.01% 4555
2024
Q3 		$7.15K Buy
+1,954
New +$7.62K ﹤0.01% 4073
2024
Q2 		– Sell
-465
Closed -$2.96K – 5866
2024
Q1 		$2.96K Buy
465
+1
+0.2% +$6 ﹤0.01% 4959
2023
Q4 		$2.18K Sell
464
-1
-0.2% -$5 ﹤0.01% 5261
2023
Q3 		$2.38K Sell
465
-2
-0.4% -$10 ﹤0.01% 5165
2023
Q2 		$2.7K Buy
467
+462
+9,240% +$9.68K ﹤0.01% 5166
2023
Q1 		$0 Sell
5
-470
-99% -$17.6K ﹤0.01% 6075
2022
Q4 		$15K Buy
+475
New +$21.9K ﹤0.01% 3426
2022
Q3 		– Sell
-35
Closed -$6K – 6297
2022
Q2 		$6K Buy
35
+5
+17% +$837 ﹤0.01% 4933
2022
Q1 		$7K Buy
30
+29
+2,900% +$7.58K ﹤0.01% 4730
2021
Q4 		$1K Sell
1
-37
-97% -$20.9K ﹤0.01% 5847
2021
Q3 		$31K Buy
+38
New +$32.3K ﹤0.01% 3353
2021
Q1 		– Sell
-1
Closed -$2K – 5564
2020
Q4 		$2K Sell
1
-3
-75% -$4.13K ﹤0.01% 4892
2020
Q3 		$6K Buy
+4
New +$6.29K ﹤0.01% 4293
2017
Q2 		– Hold
0
– -$1K – 3102
2017
Q1 		– Hold
0
– – – 2805
2016
Q4 		– Hold
0
– -$2K – 4142
2016
Q3 		– Hold
0
– – – 3092
2016
Q2 		– Hold
0
– – – 3711
2016
Q1 		– Hold
0
– – – 3118
2015
Q4 		– Sell
-2
Closed -$28K – 4782
2015
Q3 		$28K Buy
+2
New +$45.8K ﹤0.01% 1454

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s KPRX Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Kiora Pharmaceuticals (KPRX) stake by 37% in Q1 2026, selling an estimated $1.24K and leaving 995 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #4578.

Tower Research Capital (TRC) first reported a position in KPRX in Q3 2015 and has held it in 19 quarters since. The position peaked at $31K in Q3 2021. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • Tower Research Capital (TRC) held 995 shares of Kiora Pharmaceuticals worth $1.92K as of Q1 2026.
  • Tower Research Capital (TRC) sold 589 Kiora Pharmaceuticals shares in Q1 2026, an estimated $1.24K.
  • Kiora Pharmaceuticals made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4578 holding.
  • Tower Research Capital (TRC) first reported a position in Kiora Pharmaceuticals in Q3 2015 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Kiora Pharmaceuticals position peaked at $31K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.